Wilson W.S. Tam
National University of Singapore
214 Papers
352 Citations
Wilson W.S. Tam is an academic researcher from National University of Singapore. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 50, co-authored 187 publications. Previous affiliations of Wilson W.S. Tam include The Chinese University of Hong Kong & South China University of Technology.
Chat about Author
Papers
Trial-level characteristics associate with treatment effect estimates: a systematic review of meta-epidemiological studies
Huan Wang,Jinlu Song,Yali Lin,Wenjie Dai,Yinyan Gao,L. Qin,Yancong Chen,Wilson W.S. Tam,Irene X.Y. Wu,Vincent C.H. Chung +9 more
TL;DR: In this article , the up-to-date empirical evidence on trial-level characteristics of randomized controlled trials associated with treatment effect estimates was presented using forest plots, and a systematic review was conducted to assess the methodological quality of ME studies using a self developed criterion.
The effectiveness of perindopril vs. lisinopril on reducing the incidence of diabetes and renal diseases: A cohort study of 20,252 patients
Martin C.S. Wong,Wilson W.S. Tam,Harry H.X. Wang,Harry H.X. Wang,Dexing Zhang,Clement S.K. Cheung,Bryan P. Yan,Stephen R. Leeder,Sian M. Griffiths +8 more
TL;DR: Adult patients who received new prescriptions of lisinopril or perindopril from 2001 to 2005 in all public hospitals and clinics in Hong Kong were included, and followed up for at least 2 years to evaluate the comparative effectiveness of different ACEIs.
5
The incidence of all-cause, cardiovascular and respiratory disease admission among 20,252 users of lisinopril vs. perindopril: A cohort study
Martin C.S. Wong,Martin C.S. Wong,David K.L. Chan,Harry H.X. Wang,Harry H.X. Wang,Wilson W.S. Tam,Clement S.K. Cheung,Bryan P. Yan,Andrew J.S. Coats,Andrew J.S. Coats,Andrew J.S. Coats +10 more
TL;DR: Findings support intra-class differences in the effectiveness of ACEIs, which could be considered by clinical guidelines when the preferred first-line antihypertensive drugs are recommended.
5
A meta-analysis on Omega-3 supplements in preventing recurrence of atrial fibrillation.
TL;DR: Current evidence does not support treatment benefit of Omega-3 fatty acids in preventing atrial fibrillation recurrence among patients who have not been treated by any conventional reversion treatment, or who have only been treated with pharmacological therapy.